Clinical Scorecard: Effects of Catheter Ablation on Ventricular Electrical Activity in Atrial Fibrillation Patients: Evaluation of Premature Ventricular Complex Frequency
At a Glance
Category
Detail
Condition
Atrial fibrillation (AF), a common cardiac arrhythmia associated with stroke, heart failure, and dementia
Key Mechanisms
Pulmonary vein isolation (PVI) via Cryoballoon (CRYO), Radiofrequency (RF), or Pulsed Field Ablation (PFA) to isolate arrhythmogenic foci
Target Population
Adults with paroxysmal or persistent AF undergoing first-time PVI without additional ablations or major complications
Care Setting
Cardiology electrophysiology units performing catheter ablation procedures with follow-up ECG monitoring
Key Highlights
PVI is a first-line treatment for AF using CRYO, RF, or PFA energy sources with distinct mechanisms of tissue ablation
The study evaluates changes in premature ventricular complex (PVC) burden at 3 and 12 months post-PVI in a real-world cohort under standard antiarrhythmic therapy
Continuous ECG monitoring and standardized follow-up protocols enable assessment of ventricular electrical activity and arrhythmia recurrence
Guideline-Based Recommendations
Diagnosis
Confirm AF diagnosis with ECG prior to ablation
Classify AF as paroxysmal or persistent per 2024 ESC guidelines
Exclude left atrial appendage thrombus via transesophageal echocardiography before PVI
Management
Perform first-time PVI using CRYO, RF, or PFA according to institutional protocols
Ensure adequate anticoagulation and sedation during ablation
Adjust antiarrhythmic drug therapy based on symptom assessment and ECG findings during follow-up
Monitoring & Follow-up
Conduct pre-procedural 24-hour ECG and post-procedural 72-hour ECG monitoring at 3 and 12 months
Instruct patients to obtain ECG documentation if AF symptoms occur
Review ECGs by specialist nurses and physicians for PVC burden and arrhythmia recurrence
Risks
Exclude patients with major procedural complications such as cardiac tamponade or significant bleeding
Monitor for potential increases in PVC burden post-ablation
Consider procedural risks and patient-specific factors when selecting ablation modality
Patient & Prescribing Data
Patients with paroxysmal or persistent AF undergoing first-time PVI under standard-of-care antiarrhythmic drug therapy
Antiarrhythmic medications were maintained as per clinical indication; PVC burden changes were evaluated in this real-world treated cohort
Clinical Best Practices
Adhere to standardized institutional PVI protocols and ESC AF classification guidelines
Use continuous and extended ECG monitoring pre- and post-ablation to assess ventricular ectopy and arrhythmia recurrence
Select ablation energy source (CRYO, RF, PFA) based on patient characteristics and physician discretion
Exclude patients with additional ablation lesions or major complications to ensure homogeneity in outcome assessment
Apply rigorous statistical methods including non-parametric tests and correction for multiple comparisons in PVC burden analysis
by Johannes Wörsdörfer, Noah Fantazi, Anas Alnaimi, Mostafa-Mahdi Emrani, Maximiliane Oldhafer, Andreas Napp, Nikolaus Marx, Matthias Daniel Zink, Michael Gramlich